U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
  1. Regulatory Information

GUIDANCE DOCUMENT

Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions Guidance for Industry March 2002

Final

Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research

This guidance is intended to assist sponsors who will be submitting information to the Clinical Trials Data Bank. The data bank was established as required under section 113 of the Food and Drug Administration Modernization Act of 1997 (Modernization Act). This guidance combines the statutory and procedural issues discussed in two previously published draft guidances on this topic. It was finalized after considering comments received on the two draft guidances.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.